News & Updates

Secondary prophylaxis with rifaximin monotherapy is significantly more efficacious than lactulose monotherapy in preventing the recurrence of overt HE and is well tolerated in patients with cirrhosis who are in overt HE remission, suggests a post hoc analysis of 2 randomized trials presented at EASL 2024

Identifying hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies may help clinicians improve management of patients with oncological diseases, suggests a study.

Treatment with vonoprazan, a potassium competitive acid blocker (P-CAB), successfully starts and sustains the healing of Los Angeles (LA) grade C/D esophagitis as compared with proton pump inhibitor (PPI) and has moderate short- and long-term safety, according to a study. On the other hand, other P-CAB therapies need more evidence to prove their advantages.

In the treatment of critically ill patients with sepsis, continuous infusion of β-lactam antibiotics does not appear to significantly reduce 90-day mortality compared with intermittent infusions, according to the results of an open-label BLING III trial.

Among individuals with type 2 diabetes (T2D), heart failure is strongly linked to worsening kidney function, such that the risk of end-stage kidney disease (ESKD) soars tenfold following heart failure events, according to a Singapore study.

Densiron, a heavier-than-water endotamponade agent, may be used in the treatment of primary rhegmatogenous retinal detachment (RRD) in eyes with predominantly inferior retinal pathology and proliferative vitreoretinopathy (PVR) grade C, as shown by its higher anatomic success rates and improved visual outcomes relative to conventional light silicone oil (LSO), suggests a study.